clinicalRSVP Expands Phase 1 Network, Joins Two California Sites
clinicalRSVP
, the nationwide network that prevents research volunteers from enrolling in multiple concurrent research studies, announced the addition of Anaheim Clinical Trials and Profil Institute for Clinical Research, Inc. to the clinicalRSVP network.
The new California sites will join participating sites in Florida and Ontario who access
clinicalRSVP.com
to check subject eligibility requirements before dosing commences. The addition of the two West Coast sites expands the reach of the clinicalRSVP site network, as well as strengthens the relevance of the network for participating sites. The goal of clinicalRSVP.com is to provide a single continental registry for all Phase 1 investigators to check and report subject eligibility criteria, thereby improving data integrity for sponsors and trial safety for participants.
ClinicalRSVP.com began operating in 2009 with five sites located in South Florida, and has since grown the network to eighteen (18) Phase 1 units across the United States and Canada.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
